ADHD in Adults: Diagnosis, Medication and Emerging Treatments — Naked Scientists

Overview

ADHD is a neurodevelopmental condition that can persist into adulthood. The podcast examines how ADHD presents in adults, what living with the condition feels like, and why formal diagnosis matters for access to treatment.

Key insights

• Two women recently diagnosed with ADHD share how their symptoms manifest in daily life, from racing thoughts to time perception challenges.
• Experts explain the neurobiology behind ADHD, including the roles of dopamine and noradrenaline.
• Current treatments and experiences with stimulant medications are discussed, along with potential side effects and individual variability in response.
• Emerging approaches like exercise, mindful practices, diet considerations, and experimental eye movement training are explored, alongside system-wide waiting times and access to care.

Overview

The podcast presents a comprehensive exploration of Attention Deficit Hyperactivity Disorder (ADHD), focusing on how the condition affects adults and what can be done about it. Host Rhys James leads a discussion with clinicians, researchers, and two individuals who have recently received ADHD diagnoses. The program situates ADHD as a neurodevelopmental condition that persists across the lifespan, with symptoms that may shift in presentation as life demands change. The episode also delves into the social and health system dimensions of ADHD, including rising referrals and waiting times for assessments and treatment.

ADHD prevalence and lived experience

Discussion begins with an overview of how widespread ADHD is, noting estimates of around 5% of children and adults affected globally, with higher rates seen in some regions. Nicola Jane Little and Tanya Martin describe what ADHD feels like in real life. Nicola uses a vivid metaphor of a mind with 3 billion thoughts racing simultaneously, making it hard to complete tasks and stay organized. Tanya likens her thinking to a plaza of trampoline-like thoughts bouncing in multiple directions, coupled with a poor sense of time. Both describe difficulties with prioritization, goal attainment, and maintaining focus, even in daily routines such as preparing meals, finishing work projects, or navigating social expectations. The conversation also touches on the moment of self-recognition when ADHD symptoms align with a published checklist or personal history, and how a formal diagnosis can provide validation and a path to support.

What ADHD is and how it is diagnosed

Jo Steer, a clinical psychologist, explains that ADHD is a neurodevelopmental condition characterized by persistent patterns of inattention, hyperactivity, and impulsivity. For a formal diagnosis, there must be evidence that these difficulties were present before the age of 12 and that they significantly impact daily functioning. The discussion covers varying prevalence by country and the genetic component of ADHD, noting a familial link but also acknowledging that ADHD can occur with no identifiable family history. Neuroimaging findings reveal group-level differences in brain structure and neurochemistry, particularly involving dopamine and noradrenaline, but these differences are not yet diagnostic at the individual level. The segment also considers whether ADHD represents an extreme of normal variation or a disorder requiring treatment, emphasizing the need for thorough clinical assessment to determine impact on daily life and the appropriateness of interventions.

Medications and personal experiences

Barbara Sahakian explains that methylphenidate (Ritalin) is a first-line pharmacological treatment for moderate to severe ADHD symptoms, with about 70% efficacy. The drug increases dopamine and noradrenaline by blocking reuptake, which can enhance attention and impulse control in many patients. The discussion notes that medication responses vary, and comorbid conditions like anxiety or depression can influence outcomes. Nicola describes how stimulants have positively changed her ability to think in a straight line and to complete tasks, while Tanya shares that she did not tolerate stimulants well. The conversation highlights the balance between benefits and side effects and underscores that treatment must be individualized and closely monitored by healthcare professionals.

Non-pharmacological approaches and emerging therapies

Ellie Dommet from King’s College London outlines several lifestyle and behavioral approaches under investigation. Exercise has robust, broad-based benefits for cognitive function generally and ADHD symptoms in particular, while dietary changes show weaker and more variable evidence. Mindfulness can improve overall well-being and may alleviate depressive or anxious symptoms that commonly accompany ADHD, though it is not proven to target ADHD symptoms in isolation. Novel behavioral interventions, such as eye movement training, are being explored as potential ways to modulate neural mechanisms underlying ADHD. The hypothesis centers on micro-saccades controlled by the superior colliculus, which may be linked to ADHD symptomatology. While promising, these approaches are still experimental and require rigorous testing.

System-level perspectives and patient care

The podcast also examines healthcare system dynamics, reporting a significant uptick in ADHD referrals and long wait times for assessment and treatment. The Nuffield Trust notes a 51% surge in ADHD medication prescriptions between 2019 and 2023, with adults aged 25 to 44 showing the sharpest increases. The data suggest rising recognition and treatment of ADHD, but waiting times of two to three years indicate substantial capacity gaps. The discussion reiterates the importance of formal assessment, access to medications, and the potential for non-pharmacological strategies to complement pharmacotherapy. Overall, the episode portrays ADHD as a complex condition that benefits from a multi-faceted approach tailored to the individual.

Takeaways

ADHD is a prevalent, lifelong condition with diverse presentations. Diagnosis remains essential to access appropriate supports and to manage symptoms effectively through medication, lifestyle changes, and evidence-based therapies. Ongoing research into non-traditional treatments and increasing capacity in healthcare systems are critical to improving outcomes for people with ADHD.